Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People With Obesity or Overweight: A Systematic Review
The researchers looked at 175 potential adverse outcomes and found that GLP-1 drugs lowered the likelihood of 42 of these outcomes and increased the likelihood of 19 adverse outcomes
Immunofixation is the only recommended confirmatory test to establish monoclonality
National Association of Insurance Commissioners Advocacy against obesity-related bias by insurance providers, American Medical Association House of Delegates (2023) Skyrocketing growth in PBM formulary exclusions continues to raise concerns about patient access, Xcenda (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
The evolution of research from identifying single high-impact gene mutations to developing more complex, multi-gene prognostic models based on comprehensive genomic, transcriptomic, and proteomic data signifies a maturation of the field [9, 23,24,25,26]
